ROME Therapeutics Stock

Develops therapies targeting repetitive DNA sequences to treat cancer and autoimmune diseases using genomics and drug discovery expertise.

Buy

Buy ROME Therapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell ROME Therapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

ROME Therapeutics develops novel therapies by exploring the vast uncharted territory of the repeatome, the portion of the human genome made up of repetitive DNA sequences. The company leverages its expertise in genomics and drug discovery to target these sequences for the treatment of cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Founded

2019

Headquarters

Cambridge, MA

Buy

Buy ROME Therapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell ROME Therapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

ROME Therapeutics Management Team

ROME Therapeutics people and management

  • Co-Founder, CEO, President, Board Member
    Rosana Kapeller
  • Co-Founder, Board Member
    Jay Parrish
  • CFO, Chief Business Officer
    Kyle Kuvalanka
  • Board Member
    Jason Hafler
  • Board Member
    Jeb Keiper
  • Board Member
    Jeff Hatfield
  • Board Member
    Krishna Yeshwant
  • Board Member
    Kristina Burow
  • Board Member
    Scott Biller
  • Board Member
    Steven Kafka
  • Chief Scientific Officer
    Heike Keilhack

Investors

Major ROME Therapeutics investors

  • Alexandria Venture Investments

  • ARCH Venture Partners

  • Bristol Myers Squibb

  • Casdin Capital

  • Eurofarma Ventures

  • Google Ventures

  • Johnson & Johnson Development Corp (JJDC)

  • Luma Group

  • Mass General Brigham (Artificial Intelligence and Digital Innovation Fund)

  • Mirae Asset Capital

  • Raycap

  • Sanofi Ventures

  • Sigmas Group

ROME Therapeutics Valuations & Financials

Gain Insights Into ROME Therapeutics Stock Valuation & Share Prices

View real-time NPM data on ROME Therapeutics stock including daily ROME Therapeutics stock price estimates, valuation history, and historical share price information. Access ROME Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track ROME Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on ROME Therapeutics? Get in touch to learn more.

Similar Companies

Explore companies

like ROME Therapeutics

  • Cerebral

    Healthcare & Life Sciences

    Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

  • Arsenalbio-Logo

    ArsenalBio

    Healthcare & Life Sciences

    Develops programmable cell therapies for cancer patients.

  • Eikon Therapeutics Inc-Logo

    Eikon Therapeutics

    Healthcare & Life Sciences

    Uses revolutionary technology to discover novel treatments for life-threatening diseases.

  • Kallyope-Logo

    Kallyope

    Healthcare & Life Sciences

    Biotech company developing therapies targeting gut-brain axis interactions to treat metabolic and neurological diseases.

  • Clio Cloud Based Legal Technology-Logo

    Clio

    Healthcare & Life Sciences

    Comprehensive legal practice management software designed to help law firms manage their operations more efficiently.

  • Array Behavioral Care

    Healthcare & Life Sciences

    Provider of telepsychiatry and telebehavioral health services.

  • Sollis Health

    Healthcare & Life Sciences

    Delivers personalized primary care and clinical services with a focus on patient‑centered care delivery.

  • Colossal Laboratories & Biosciences

    Healthcare & Life Sciences

    Pioneering biotech that reconstructs genomes for species restoration and ecosystem revitalization with innovative genetic engineering.

  • Avalyn Pharma

    Healthcare & Life Sciences

    Develops inhaled therapies for rare respiratory diseases like idiopathic pulmonary fibrosis and interstitial lung diseases.

FAQ

Questions?

We have answers

Buy ROME Therapeutics Stock

ROME Therapeutics stock does not trade on public stock exchanges. ROME Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in ROME Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell ROME Therapeutics Stock

ROME Therapeutics Stock does not trade on public stock exchanges. In order to sell ROME Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

ROME Therapeutics Stock Price

ROME Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view ROME Therapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

ROME Therapeutics Stock Ticker Symbol

There is no ticker symbol for ROME Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell ROME Therapeutics Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell ROME Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in ROME Therapeutics Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in ROME Therapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

ROME Therapeutics Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

ROME Therapeutics IPO

ROME Therapeutics is a private company and has not had an IPO. There is currently no ROME Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to ROME Therapeutics IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.